Literature DB >> 15837113

Treatment of latent tuberculosis infection: challenges and prospects.

Kelly E Dooley1, Timothy R Sterling.   

Abstract

This article reviews the treatment of latent tuberculosis infection in HIV-seropositive and HIV-seronegative persons.

Entities:  

Mesh：

Year:  2005        PMID： 15837113     DOI： 10.1016/j.ccm.2005.02.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  5 in total

1.  Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.

Authors:  Areej M Abuhammad; Edward D Lowe; Elizabeth Fullam; Martin Noble; Elspeth F Garman; Edith Sim
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

2.  T-SPOT.TB: an in vitro diagnostic assay measuring T-cell reaction to Mycobacterium tuberculosis-specific antigens.

Authors:  Antona J Wagstaff; Jean-Pierre Zellweger
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Proposed management of childhood tuberculosis in low-incidence countries.

Authors:  Klaus Magdorf; Anne K Detjen
Journal:  Eur J Pediatr       Date:  2008-05-10       Impact factor: 3.183

4.  Prevalence of latent tuberculosis infection and associated risk factors in an urban African setting.

Authors:  Florence N Kizza; Justin List; Allan K Nkwata; Alphonse Okwera; Amara E Ezeamama; Christopher C Whalen; Juliet N Sekandi
Journal:  BMC Infect Dis       Date:  2015-03-29       Impact factor: 3.090

5.  Management of latent tuberculosis infections in australia and new zealand: a review of current practice.

Authors:  Justin T Denholm; Emma S McBryde
Journal:  Tuberc Res Treat       Date:  2010-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.